| http://www.w3.org/ns/prov#value | - The largest trial of these agents showed no improvement in oral dryness, ocular dryness, or objective tests, including the Schirmer test and focus score on labial salivary gland biopsy.8 In this study, 103 patients were randomized to infliximab (Remicade) infusions or placebo and evaluated at 10 and 22 weeks.
|
